Investing.com - Gilead (NASDAQ:GILD) reported on Tuesday second quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Gilead announced earnings per share of $1.58 on revenue of $6.26B. Analysts polled by Investing.com anticipated EPS of $1.52 on revenue of $5.86B.
Gilead shares are down 18% from the beginning of the year and are trading at $58.65 , down-from-52-week-high.They are under-performing the S&P 500 which is down 14.14% from the start of the year.
Gilead shares lost 1.49% in after-hours trade the report.
Gilead follows other major Healthcare sector earnings this month
Gilead's report follows an earnings beat by UnitedHealth on Friday, July 15, 2022, who reported EPS of $5.57 on revenue of $80.33B, compared to forecasts EPS of $5.21 on revenue of $79.68B.
J&J had beat expectations on Tuesday, July 19, 2022 with second quarter EPS of $2.59 on revenue of $24.02B, compared to forecast for EPS of $2.54 on revenue of $23.77B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar